Paclitaxel-Based Chemotherapy for Advanced Pancreatic Cancer after Gemcitabine-Based Therapy Failure: A Case Series of 5 Patients

Background/Objectives: Gemcitabine (GEM) is a gold-standard chemotherapy agent for advanced pancreatic cancer. Because of the malignant character of the disease, nearly all patients show disease progression despite treatment with GEM-based chemotherapy; therefore, second-line chemotherapy may be ben...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Case reports in oncology 2011-01, Vol.4 (3), p.534-541
Hauptverfasser:	Igarashi, Hisato, Ito, Tetsuhide, Hisano, Terumasa, Fujimori, Nao, Niina, Yusuke, Yasuda, Mikihiko, Kaku, Toyoma, Matsuo, Susumu, Oono, Takamasa, Yoshinaga, Masahiro, Sakai, Hiroyuki, Takayanagi, Ryoichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy Gemcitabine failure Paclitaxel Pancreatic cancer Published: November 2011 Second-line therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!